The effect of dexmedetomidine on agitation during weaning of mechanical ventilation in critically ill patients

Anaesthesia and Intensive Care

Volumn 38, Issue 1, 2010, Pages 82-90

  Shehabi, Y ^a,b   Nakae, H ^a,c   Hamond, N ^a,d   Bass, F ^a,e   Nicholson, L ^a,e   Chen, J ^a,f  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d THE PRINCE CHARLES HOSPITAL   (Australia)

^e Intensive Care Unit

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Agitation; Critical care; Dexmedetomidine; Sedation; Ventilation weaning

Indexed keywords

ADRENALIN; ALPRAZOLAM; DEXMEDETOMIDINE; DOBUTAMINE; FENTANYL; HALOPERIDOL; KETAMINE; MIDAZOLAM; MORPHINE; NORADRENALIN; OPIATE; PROPOFOL; SEDATIVE AGENT;

ADD ON THERAPY; ADULT; AGED; AGITATION; ANALGESIA; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DELIRIUM; DETERIORATION; DRUG DOSE TITRATION; EXTUBATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; MAXIMUM PERMISSIBLE DOSE; MOTOR ACTIVITY; OBSERVATIONAL STUDY; OPEN STUDY; PROSPECTIVE STUDY; SCORING SYSTEM; SEDATION; TREATMENT FAILURE;

EID: 75749123851     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x1003800115     Document Type: Article

References (33)

1. K ress JP, Hall JB. Sedation in the mechanically ventilated patient. Crit Care Med 2006; 34:2541-2546.
2. Woods JC, Mion LC, Connor JT, Viray F, Jahan L, Huber C et al. Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med 2004; 30:1066-1072.
3. Chanques G, Jaber S, Barbotte E, Violet S, Sebbane M, Perrigault P-F et al. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med 2006; 34:1691-1699.
4. Girard TD, Shintani AK, Jackson JC, Gordon SM, Pun BT, Henderson MS et al. Risk factors for post-traumatic stress disorder symptoms following critical illness requiring mechanical ventilation: a prospective cohort study. Crit Care 2007; 11:R28.
5. MacIntyre NR, Cook DJ, Ely EW Jr, Epstein SK, Fink JB, Heffner JE et al. Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest 2001; 120:375S-95S.
6. Cook D, Meade M, Guyatt G, Butler R, Aldawood A, Epstein S. Trials of miscellaneous interventions to wean from mechanical ventilation. Chest 2001; 120:438S-444S.
7. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119-141.
8. Arbour R. Propylene glycol toxicity occurs during low-dose infusions of lorazepam. Crit Care Med 2003; 31:664-665; author reply 665.
9. Caroff SN, Rosenberg H, Mann SC, Campbell EC, Sullivan KA. Neuroleptic malignant syndrome in the critical care unit. Crit Care Med 2002; 30:2609; author reply 2609-2610.
10. Price SR. Rotation of propofol and midazolam for long-term sedation. Crit Care Med 2004; 32:1435-1436; author reply 1436.
11. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27:2609-2615.
12. K ress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-1477.
13. Schweickert WD, Kress JP. Strategies to optimize analgesia and sedation. Crit Care 2008; 12 (Suppl 3):S6.
14. Szumita PM, Baroletti SA, Anger KE, Wechsler ME. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm 2007; 64:37-44.
15. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000; 4:302-308.
16. Devlin JW, Boleski G, Mlynarek M, Nerenz DR, Peterson E, Jankowski M et al. Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med 1999; 27:1271-1275.
17. Corbett SM, Rebuck JA, Greene CM, Callas PW, Neale BW, Healey MA et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med 2005; 33:940-945.
18. Dasta JF, Jacobi J, Sesti A-M, McLaughlin TP. Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis. Pharmacotherapy 2006; 26:798-805.
19. Herr DL, Sum-Ping STJ, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003; 17:576-584.
20. MacLaren R, Forrest LK, Kiser TH. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy 2007; 27:351-359.
21. Martin E, Ramsay G, Mantz J, Sum-Ping ST. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003; 18:29-41.
22. Siobal MS, Kallet RH, Kivett VA, Tang JF. Use of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation: a pilot study. Respir Care 2006; 51:492-496.
23. Takrouri MS, Seraj MA, Channa AB, el-Dawlatly AA, Thallage A, Riad W et al. Dexmedetomidine in intensive care unit: a study of hemodynamic changes. Middle East J Anesthesiol 2002; 16:587-595.
24. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54:1136-1142.
25. Terajima K, Takeda S, Taniai N, Tanaka K, Oda Y, Asada A et al. Repeated dexmedetomidine infusions, a postoperative living-donor liver transplantation patient. J Anesth 2006; 20:234-236.
26. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301:489-499.
27. Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003; 29:201-207.
28. K obayashi A, Okuda T, Kotani T, Oda Y. [Efficacy of dexmedetomidine for controlling delirium in intensive care unit patients]. Masui 2007; 56:1155-1160.
29. Multz AS. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003; 96:1054-1055.
30. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004; 30:2188-2196.
31. Precedex Prescribing Information. eMIMS Australia; 2003.
32. K limscha W, Tong C, Eisenach JC. Intrathecal alpha 2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study. Anesthesiology 1997; 87:110-116.
33. Mussi C, Ferrari R, Ascari S, Salvioli G. Importance of serum anticholinergic activity in the assessment of elderly patients with delirium. J Geriatr Psychiatry Neurol 1999; 12:82-86.